IP Verse

Grindeks, A Joint Stock Company opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

May 13, 2020

Title:

Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3135275	May 13, 2020	Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications	3

BACHELIN, MARTIN

HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

SYNTHON BV

Feel free to send us a message here and we will get back to you